Patrice Rioux sold $111 of MNPR stock

Patrice Rioux, Other of Monopar Therapeutics (MNPR), sold 1 shares of MNPR stock worth $111, per an SEC Form 4 filed Aug 27, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 26, 2026, 1 day before it was made public.

MNPR has moved -37.2% since the trade date, from $113.72 to $71.42 (Nov 6, 2026 close).